MorphoSys's AbD Serotec unit will develop and qualify antibodies from MorphoSys's proprietary HuCAL GOLD library against a committed number of targets identified and supplied by Sigma-Aldrich. HuCAL GOLD is the powerful phage-display library developed for the in vitro generation of highly specific and fully human antibodies.
The large diversity of the library guarantees fast and successful generation of high-quality antibodies to targets that have previously been difficult to probe with standard antibody-generation technologies.
Sigma-Aldrich will offer the HuCAL-based recombinant research antibodies for use in research applications through its online sales platforms Antibody Explorer™ and Your Favorite Gene Search™.
"We are very excited about the potential of this partnership," said Dr. David Smoller, president of Sigma-Aldrich's Research Biotech business unit. "HuCAL-based recombinant antibody technology will allow researchers access to antibody content not available through standard antibody generation technologies. In conjunction with Sigma-Aldrich's standard content generation capabilities, this powerful technology is expected to allow the community to reach its goal of a binder for every gene and one-day even protein in the human body."